News

  • TRANSFORM II trial at TCT 2026

    TRANSFORM II will be featured at TCT 2026 as a Late-Breaking Clinical Trial.

    -

    Presented by Prof. Bernardo Cortese, the study compares a sirolimus-coated balloon with a drug-eluting stent in native coronary vessels. CERC is proud to contribute to this international trial across 14 sites in Bangladesh, Malaysia, Brunei, Thailand and Poland, supporting key activities including...

  • A new milestone for the LEAVE NOTHING BEHIND trial in Latvia.

    A new milestone for the LEAVE NOTHING BEHIND trial in Latvia

    -

    The first patient in Latvia was enrolled on October 1 at Paula Stradiņa Klīniskā universitātes slimnīca in Riga, under the leadership of Principal Investigator Prof. Andrejs Erglis. Congratulations to Prof. Ērglis and the entire study team for reaching this important milestone. Sponsored by CERIC...

  • First enrollment for the CLARIT trial in India

    First enrollment for the CLARIT trial in India

    -

    The first two patients have been enrolled at Breach Candy Hospital Trust in Mumbai, under the leadership of Principal Investigator Dr. Kirti Punamiya. Congratulations to Dr. Punamiya and the entire study team for achieving this important step. As the CRO supporting this international registry study...

  • 𝗦𝗧𝗔𝗥𝗧 𝗬𝗢𝗨𝗡𝗚 𝗦𝘁𝘂𝗱𝘆 first patient 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗶𝗮

    A new milestone for the Start Young Study in Austria

    -

    We are delighted to announce that the 𝗳𝗶𝗿𝘀𝘁 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗲𝗻𝗿𝗼𝗹𝗹𝗲𝗱 𝗶𝗻 𝗚𝗿𝗮𝘇 in the 𝗦𝗧𝗔𝗥𝗧 𝗬𝗢𝗨𝗡𝗚 𝗦𝘁𝘂𝗱𝘆 — an important step forward for this international clinical research initiative. A warm congratulations and sincere thanks to 𝗣𝗿𝗼𝗳. 𝗔𝗹𝗯𝗿𝗲𝗰𝗵𝘁 𝗦𝗰𝗵𝗺𝗶𝗱𝘁, 𝗣𝗿𝗼𝗳. Martin Andreas, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗲𝗻𝘁𝗶𝗿𝗲 𝘁𝗲𝗮𝗺 𝗮𝘁...

  • Expanding the Leave Nothing Behind Study across Europe — Slovakia is now Recruiting

    Expanding the Leave Nothing Behind Study across Europe — Slovakia is now Recruiting

    -

    Congratulations to Dr PeterKirsch and his team at VÚSCH - Východoslovenský ústav srdcových a cievnych chorôb, a.s., Košice, on reaching this important milestone and opening recruitment in Slovakia. The addition of another participating country strengthens the international momentum of the study and...

  •  first patients now enrolled in Poland at the Institute of Cardiology in Warsaw

    START YOUNG expands into Poland — First patients enrolled

    -

    A significant milestone for the START YOUNG Study, with the first patients now enrolled in Poland at the Institute of Cardiology in Warsaw. Congratulations to Prof. Maciej Dąbrowski, Prof.Adam Witkowski, Dr. Rafał Wolny, and the entire catheterization laboratory team for reaching this important...

  • First patient enrolled in Belgium for the LEAVE NOTHING BEHIND study

    First patient enrolled in Belgium for the LEAVE NOTHING BEHIND study

    -

    🌍 New country. New patients. One step further for LEAVE NOTHING BEHIND. We are pleased to celebrate another important step in the LEAVE NOTHING BEHIND study with the enrollment of the first patient in Belgium 🇧🇪. Congratulations to Dr. Alexandre Natalis and his cath-lab team at Grand Hôpital de...

  • Clarit study First patients enrolled in Spain

    First patients enrolled in the CLARIT trial

    -

    The CLARIT trial has reached an important milestone with the enrollment of its first patients in Spain. The first three patients were enrolled by Dr. Alfonso Jurado Román and the team at La Paz University Hospital in Madrid, marking the start of patient recruitment in Spain for this international...

  • LAARC Consensus

    LAARC consensus published in the European Heart Journal

    -

    Cardiovascular European Research Center (CERC) is proud to announce the publication of the Left Atrial Appendage Academic Research Consortium (LAARC) consensus in the European Heart Journal. Developed over three years through an international collaborative effort, this landma rk publication...

  • First German patient enrolled in the Leave Nothing Behind study

    New milestone in Leave Nothing Behind Study

    -

    We are pleased to celebrate another important milestone in the LNB Study! Congratulations to Prof. Dr. Holger Nef and the team in Herz- und Gefäßzentrum Segeberger Kliniken Gruppe on enrolling their first patient in the study. This marks an exciting step forward and reflects the team's commitment to...